Lilly makes preclinical ADC specialist CrossBridge its latest acquisition in vague $300M deal Read more →
Alamar Biosciences files for IPO amid opening life sciences funding window Read more →
Harbinger Health raises $100M for new suite of blood-based cancer detection tests Read more →